Hamada K - Search Results

1

Tailored therapeutic strategies for synovial sarcoma: receptor tyrosine kinase pathway analyses predict sensitivity to the mTOR inhibitor RAD001.

Yasui H, Naka N, Imura Y, Outani H, Kaneko K, Hamada K, Sasagawa S, Araki N, Ueda T, Itoh K, Myoui A, Yoshikawa H. Yasui H, et al. Among authors: hamada k. Cancer Lett. 2014 May 28;347(1):114-22. doi: 10.1016/j.canlet.2014.01.027. Epub 2014 Jan 31. Cancer Lett. 2014. PMID: 24491407

2

Peripheral nerve schwannoma: two cases exhibiting increased FDG uptake in early and delayed PET imaging.

Hamada K, Ueda T, Higuchi I, Inoue A, Tamai N, Myoi A, Tomita Y, Aozasa K, Yoshikawa H, Hatazawa J. Hamada K, et al. Skeletal Radiol. 2005 Jan;34(1):52-7. doi: 10.1007/s00256-004-0845-z. Epub 2004 Oct 9. Skeletal Radiol. 2005. PMID: 15480645

3

FDG-PET imaging for chronic expanding hematoma in pelvis with massive bone destruction.

Hamada K, Myoui A, Ueda T, Higuchi I, Inoue A, Tamai N, Yoshikawa H, Hatazawa J. Hamada K, et al. Skeletal Radiol. 2005 Dec;34(12):807-11. doi: 10.1007/s00256-005-0895-x. Epub 2005 Apr 15. Skeletal Radiol. 2005. PMID: 15834566

4

False positive 18F-FDG PET in an ischial chondroblastoma; an analysis of glucose transporter 1 and hexokinase II expression.

Hamada K, Ueda T, Tomita Y, Higuchi I, Inoue A, Tamai N, Myoui A, Aozasa K, Yoshikawa H, Hatazawa J. Hamada K, et al. Skeletal Radiol. 2006 May;35(5):306-10. doi: 10.1007/s00256-005-0032-x. Epub 2005 Dec 7. Skeletal Radiol. 2006. PMID: 16333655

5

Myoepithelioma of soft tissue originating from the hand: 18F-FDG PET features.

Hamada K, Ueda T, Tomita Y, Yoshikawa H, Hatazawa J. Hamada K, et al. AJR Am J Roentgenol. 2006 Jan;186(1):270-1. doi: 10.2214/AJR.05.0191. AJR Am J Roentgenol. 2006. PMID: 16357423 No abstract available.

6

Prognostic significance of activated AKT expression in soft-tissue sarcoma.

Tomita Y, Morooka T, Hoshida Y, Zhang B, Qiu Y, Nakamichi I, Hamada K, Ueda T, Naka N, Kudawara I, Aozasa K. Tomita Y, et al. Among authors: hamada k. Clin Cancer Res. 2006 May 15;12(10):3070-7. doi: 10.1158/1078-0432.CCR-05-1732. Clin Cancer Res. 2006. PMID: 16707604

7

Reassessment of the 1993 Osaka grading system for localized soft tissue sarcoma in Japan.

Tomita Y, Morooka T, Hoshida Y, Zhang B, Qiu Y, Nakamichi I, Hamada K, Ueda T, Naka N, Kudawara I, Aozasa K. Tomita Y, et al. Among authors: hamada k. Anticancer Res. 2006 Nov-Dec;26(6C):4665-9. Anticancer Res. 2006. PMID: 17214324 Free article.

8

Evaluation of delayed 18F-FDG PET in differential diagnosis for malignant soft-tissue tumors.

Hamada K, Tomita Y, Ueda T, Enomoto K, Kakunaga S, Myoui A, Higuchi I, Yoshikawa H, Hatazawa J. Hamada K, et al. Ann Nucl Med. 2006 Dec;20(10):671-5. doi: 10.1007/BF02984678. Ann Nucl Med. 2006. PMID: 17385305

9

Prognostic significance of CD100 expression in soft tissue sarcoma.

Ch'ng E, Tomita Y, Zhang B, He J, Hoshida Y, Qiu Y, Morii E, Nakamichi I, Hamada K, Ueda T, Aozasa K. Ch'ng E, et al. Among authors: hamada k. Cancer. 2007 Jul 1;110(1):164-72. doi: 10.1002/cncr.22764. Cancer. 2007. PMID: 17520683 Free article.

10

18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.

Hamada K, Tomita Y, Qiu Y, Zhang B, Ueda T, Myoui A, Higuchi I, Yoshikawa H, Aozasa K, Hatazawa J. Hamada K, et al. Ann Nucl Med. 2008 Oct;22(8):699-705. doi: 10.1007/s12149-008-0173-9. Epub 2008 Nov 4. Ann Nucl Med. 2008. PMID: 18982473

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,718 results

Search Page

Filters